A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro

References

• ADEN, D. P., FOGEL, A., PLOTKIN, S., DAMJANOV, I. and KNOWLES, B. B., 1979, Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature, 282, 615–616.
   PubMed Web of Science ®Google Scholar
• AOYAMA, T., YAMANO, S., GUZELIAN, P. S., GELsous, H. V. and GONZALEZ, F. J., 1990, Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B. Proceedings of the National Academy of Sciences, USA, 87, 4790–4793.
   PubMed Web of Science ®Google Scholar
• BARWICK, J., QUATTROCHI, L., MILLS, A. S., POTENZA, C., TUKEY, R. H. and GUZELIAN, P. S., 1996, Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Molecular Pharmacology, 50, 10–16.
   PubMed Web of Science ®Google Scholar
• BEATO, M., 1989, Gene regulation by steroid hormones. Cell, 56, 335–344.
   PubMed Web of Science ®Google Scholar
• BURGER, H.-J., SCHUETZ, J. D., SCHUETZ, E. G. and GUZELIAN, P. S., 1992, Paradoxical transcriptional activation of rat liver cytochrome P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16a-carbonitrile : analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes. Proceedings of the National Academy of Sciences, USA, 89, 2145–2149.
   PubMed Web of Science ®Google Scholar
• CASHMAN, J. R., 1996, Drug discovery and drug metabolism. Drug Discovery Today, 1, 209–216.
   Web of Science ®Google Scholar
• CHOLERTON, S., DALY, A. K. and IDLE, J. R., 1992, The role of individual human cytochromes P450 in drug metabolism and clinical response. TIPS, 13, 434–439.
   PubMed Web of Science ®Google Scholar
• CURI-PEDROSA, R., DAUJAT, M., PICHARD, L., OURLIN, J. C., CLAIR, P., GERVOT, L., LESCA, P., DOMERGUE, J., JoYEux, H., FOURTAN1ER, G. and MAUREL, P., 1994, Omeprazole and lansoprazole are mixed inducers of CYP 1A and CYP 3A in human hepatocytes in primary culture. Journal of Pharmacology and Experimental Therapeutics, 269, 384–392.
   Google Scholar
• EVANS, R. M., 1988, The steroid and thyroid hormone receptor superfamily. Science, 240, 889-895. FENSKE, M., 1991, Protein binding of cortisol by means of competitive adsorption: application to cortisol binding by serum of sixteen eutherian mammals. Comparative Biochemistry and Physiology, 98, 61–66.
   Google Scholar
• FERRO, M., BASSI, A. M., PENCO, S. and NANNI, G., 1993, Use of established hepatoma cell lines in biotoxicology. Cytotechnology, 11, S126–129.
   Web of Science ®Google Scholar
• FUKUDA, Y., ISHIDA N., NOGUCHI, T., KAPPAS, A. and SASSA, S., 1992, Interleukin 6 down regulates the expression of transcripts encoding cytochrome P450 1A1, 1A2 and IIIA3 in human hepatoma cells. Biochemical and Biophysical Research Communications, 184, 960–965.
   Google Scholar
• GERVOT, L., CARR1ERE, V., COSTET, P., CUGENC, P.-H., BERGER, A., BEAUNE, P. and WAZ1ERS, I. D., 1996, CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines. Environmental Toxicology and Pharmacology, 2, 381–388.
   Google Scholar
• GUENGERICH, F. P., 1990, Mechanism-based inactivation of human liver microsomal cytochrome P-450 II1A4 by gestodene. Chemical Research in Toxicology, 3, 363–371.
   PubMed Web of Science ®Google Scholar
• HASHIMOTO, H., TOIDE, K., KITAMURA, R., FUJITA, M., TAGAWA, S., ITOH, S. and KAMATAKI, T., 1993, Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers and its transcriptional control. European Journal of Biochemistry, 218, 585–595.
   PubMedGoogle Scholar
• HOSTETLER, K. A., WRIGHTON, S. A., MOLOWA, D. T., THOMAS, P. E., LEVIN, W. and GUZELIAN, P. S., 1988, Co-induction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents. Molecular Pharmacology, 35, 279–285.
   Web of Science ®Google Scholar
• Huss, J. M., WANG, S. I., ASTROM, A., MCQUIDDY, P. and KASPER, C. B., 1996, Dexamethasone responsiveness of a major glucocorticoid-inducible CYP3A gene is mediated by elements unrelated to a glucocorticoid receptor binding motif. Proceedings of the National Academy of Sciences, USA, 93, 4666–4670.
   PubMed Web of Science ®Google Scholar
• JORDAN, M., SCHALLHORN, A. and WURM, F. M., 1996, Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Research, 24, 596–601.
   PubMed Web of Science ®Google Scholar
• JOUNAIDI, Y., GUZELIAN, P. S., MAUREL, P. and VILAREM, M.-J., 1994, Sequence of the 51flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7. Biochemical and Biophysical Research Communications, 205, 1741–1747.
   Google Scholar
• KETTER, T. A., FLOCKHART, D. A., POST, R. M., DENICOFF, K., PAZZAGLIA, P. J., MARANGELL, L. B., GEORGE, M. S. and CALLAHAN, A. M., 1995, The emerging role of cytochrome P450 3A in psychopharmacology. Journal of Clinical Psychopharmacology, 15, 387–398.
   PubMed Web of Science ®Google Scholar
• KITADA, M., KAMATAKI, T., ITAHASHI, K., RIKIHISA, T., KATO, R. and KANAKUBO, Y., 1985, Purification and properties of cytochrome P-450 from homogenates of human fetal livers. Archives of Biochemistry and Biophysics, 241, 275–280.
   PubMed Web of Science ®Google Scholar
• KL1EWER, S. A., MOORE, J. T., WADE, L., STAUDINGER, J. L., WATSON, M. A., Jos, S. A., McKEE, D. D., OLIVER, B. B., WILLSON, T. M., ZETTERSTROM, R. H., PEREVIANN, T. and LEHMANN, J. M., 1998, An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell, 92, 73–82.
   Google Scholar
• KOLARS, J. C., LOWN, K. S., SCHM1EDLIN -REN, P., GHOSH, M., FANG, C., WRIGHTON, S. A., MERION, R. M. and WATKINS, P. B., 1994, CYP3A gene expression in human gut epithelium. Pharmacoge-netks, 4, 247–259.
   Google Scholar
• KOLARS, J. C., SCHM1EDLIN -REN, P., SCHUETZ, J. D., FANG, C. and WATKINS, P. B., 1992, Identification of rifampicin-inducible P450 II1A4 (CYP3A4) in human small bowel enterocytes. Journal of Clinical Investigation, 90, 1871–1878.
   Google Scholar
• KOMORI, M., HASHIZUME, T., OHI, H., MIURA, T., KITADA, M., NAGASHIMA, K. and KAMATAKI, T., 1988, Cytochrome P-450 in human liver microsomes : high-performance liquid chromatographic isolation of three forms and their characterisation. Journal of Biochemistry, 104, 912–916.
   PubMed Web of Science ®Google Scholar
• KRIVORUK, Y., KINIRONS, M. T., WOOD, A. J. J. and WOOD, M., 1994, Metabolism of cytochrome P450 3A substrates in vivo administered by the same route. Lack of correlation between alfentanil clearance and erythromycin breath test. Clinical Pharmacology and Therapeutics, 56, 608–614.
   Google Scholar
• LARSEN, M. C., BRAKE, P. B., PARMAR, D. and JEFCOATE, C. R., 1994, The induction of five rat hepatic P450 Cytochromes by phenobarbital and similarly acting compounds is regulated by a sexually dimorphic, dietary-dependent endocrine factor that is highly strain specific. Archives of Biochemistry and Biophysics, 315, 24–34.
   PubMed Web of Science ®Google Scholar
• NELSON D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS I. C., GOTOH, 0., OKUDA, K. and NEBERT, D. W., 1993, The P450 superfamily : update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA and Cell Biology, 12, 1–51.
   Google Scholar
• NELSON D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, 0., COON, M. J., ESTABROOK, R. W., GUNSALUS I. C. and NEBERT D. W., 1996, P450 superfamily : update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   Google Scholar
• OGG, M. S., GRAY, T. J. B. and GIBSON, G. G., 1997, Development of an in vitro reporter gene assay to assess xenobiotic induction of the human CYP3A4 gene. European Journal of Drug Metabolism and Pharmacokinetics, 22, 311–313.
   Google Scholar
• PICKWELL, G. V., QUATTROCHI, L., SHIH, H. and GUZELIAN, P. S., 1996, Transcriptional activation of human fetal cytochrome P450 CYP3A7. FASEB Journal, 1346.
   Google Scholar
• QUATTROCHI, L., MILLS, A. S., BARWICK, J. L., YOCKEY, C. B. and GUZELIAN, P. S., 1995, A novel cis-acting element in a liver cytochrome P450 3A gene confers synergistic induction by glucocorticoids plus antiglucocorticoids. Journal of Biological Chemistry, 270, 28917–28923.
   PubMed Web of Science ®Google Scholar
• SCHUETZ, E. G., SCHUETZ, J. D., STROM, S. C., THOMPSON, M. T., FISHER, R. A., MOLOWA, D. T., Li, D. and GUZELIAN, P. S., 1993, Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology, 18, 1254–1262.
   PubMed Web of Science ®Google Scholar
• SCHUETZ, J. D., BEACH, D. L. and GUZELIAN, P. S., 1994, Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics, 4, 11–20.
   PubMedGoogle Scholar
• SCHUETZ, J. D., KAUMA, S. and GUZELIAN, P. S., 1993, Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. Journal of Clinical Investigation, 92, 1018–1024.
   PubMed Web of Science ®Google Scholar
• SCHUETZ, J. D., SCHUETZ, E. G., THOTTASSERY, J. V., GUZELIAN, P. S., STROM, S. C. and SUN, D., 1996, Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Molecular Pharmacology, 49, 63–72.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MIMUA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• TOMLINSON, R., YOUNG, R. P., NG, M. C. Y., ANDERSON, P. J., KAY, R. and CRITCHLEY, J. A. J. H., 1996, Selective liver enzyme induction by carbamazepine and phenytoin in Chinese epileptics. Journal of Clinical Pharmacology, 50, 411–415.
   Google Scholar
• WATKINS, P. B., MURRAY, S. A., WINICELMAN, L. G., HEUMAN, D. M., WRIGHTON, S. A. and GUZELIAN P. S., 1989, Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Journal of Clinical Investigation, 83, 688–697.
   Google Scholar
• WATKINS, P. B., WRIGHTON, S. A., SCHUETZ, E.G., MAUREL, P. and GUZELIAN, P. S., 1986, Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer culture. Journal of Biological Chemistry, 261, 6264–6271.
   PubMed Web of Science ®Google Scholar
• WEBER, M., MOLLER, K., WELZEK, M. and SCHORR, J., 1996, Effect of endotoxins on transfection efficiency in eukaryotic cells. Qiagen News, 4–5.
   Google Scholar
• WILLIAMS, J. A., CHENERY, R. J. and HAWKSWORTH, G. M., 1994, Induction of CYP3A enzymes in human and rat hepatocyte cultures. Biochemical Society Transactions, 22, 131s.
   PubMed Web of Science ®Google Scholar
• WILLIAMS, J. M. 1997, Drug regulation of the human cytochrome P450 gene, CYP 3A4. PhD thesis, University of Surrey.
   Google Scholar
• WRIGHT, M. C. and PAINE, A. J., 1994, Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding if inducers to a microsomal protein. Biochemical and Biophysical Research Communications, 201, 973–979.
   PubMed Web of Science ®Google Scholar